QA: Oncocyte Corp in us_medicinal_products/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001642380_2022_Oncocyte_Corp.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001642380, Oncocyte Corp

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 14,120,000
2 remainder_Liabilities 80,226,000
3 AssetsCurrent 39,143,000
4 AssetsNoncurrent 264,000
5 PropertyPlantAndEquipmentNet 0
6 Goodwill 109,929,000
7 remainder_Assets 10,227,000
8 GeneralAndAdministrativeExpense 37,688,000
9 ResearchAndDevelopmentExpense 13,631,000
10 remainder_Expenses 21,359,000
11 remainder_Revenues 7,727,000
12 remainder_NetIncome 854,000
13 remainder_ComprehensiveNetIncome 37,000
  yvar yval
0 Liabilities 94,346,000
1 Assets 159,563,000
2 Expenses 72,678,000
3 Revenues 7,727,000
4 StockholdersEquity 65,217,000
5 NetIncome -64,097,000
6 ComprehensiveNetIncome -64,078,500
7 BaseVar 167,602,500
8 EconomicCapitalRatio -0.0681

Edgar->Model Mapping

Feature Distribution

Change over Time